When Yael Mossé, MD, was awarded a Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) in 2003, she wanted to find a familial cancer gene in the rare, hereditary form of pediatric neuroblastoma. She imagined that finding such a gene would also be relevant in helping researchers understand the more common, sporadic form of neuroblastoma. It was only “a pie-in-the-sky dream” at that point, according to Dr. Mossé, that this gene would turn out to be a targetable oncogene and that her early research would lead to an extremely promising clinical trial on a new treatment for pediatric cancers. Learn more about Dr. Mossé’s study, which is being featured in the 2012 ASCO Annual Meeting press program.